Abstract

Oral cancer is the sixth most common cancer in the world. It accounts for approximately 4% of all cancers and 2% of all cancer deaths worldwide. Malignant tumors of the oral cavity account for approximately 30% of all head and neck cancers. With an incidence rate of invasive lip and oral cavity tumors in The Netherlands rising to 6.6%, oral cancer is a common malignancy that often requires resection of the tumor followed by reconstruction.

mucosal substitutes, oral cancer, head and neck cancers
S.E.R. Hovius (Steven)
Erasmus University Rotterdam
Allergan Artu Biologicals Biomet Bioprof Bloom Medical Covidien Dutch Burns Foundation Emdaplast Erasmus University Rotterdam Copyright © Hinne A Rakhorst Esser foundation Johnson & Johnson: Mitek, Woundcare and Ethicon KCI Molnlycke Dutch Society for Plastic and Reconstructive Surgery Valeant
978-90-90-22975-1
hdl.handle.net/1765/11767
Erasmus MC: University Medical Center Rotterdam

Rakhorst, H.A. (2008, May 9). Cultured Mucosal Substitutes; from Lab Bench towards Bedside?. Erasmus University Rotterdam. Retrieved from http://hdl.handle.net/1765/11767